The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study.
about
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationProphylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantationIndications for platelet transfusion in patients with thrombocytopeniaDose of prophylactic platelet transfusions and prevention of hemorrhagePlatelet transfusion prophylaxis for patients with haematological malignancies: where to now?Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials.Platelet dose for prophylactic platelet transfusions.Platelet transfusions for patients with haematological malignancies: who needs them?The observation of bleeding complications in haemato-oncological patients: stringent watching, relevant reporting.A pilot study to assess the hemostatic function of pathogen-reduced platelets in patients with thrombocytopenia.Hemostatic function and transfusion efficacy of apheresis platelet concentrates treated with gamma irradiation in use for thrombocytopenic patients.Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot studyGuidelines for the transfusion of platelets.The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions.Clinical effectiveness and comparative hospital costs of different platelet dose strategies.Platelet transfusion: a systematic review of the clinical evidence.Development of the Platelet Efficacy Score (PEscore) to predict the efficacy of platelet transfusion in oncohematologic patients.The association between platelet transfusion and idiopathic pneumonia syndrome is unaffected by platelet product type.Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial.Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.Platelet concentrates from fresh or overnight-stored blood, an international study.
P2860
Q24186359-44551B8D-5BDB-430F-AA13-A519E54346D4Q24186913-3AC0F5EA-F175-4687-BC9D-B42E88E2E24CQ24187751-61C475F2-3847-4681-85FC-1FD489CA32B0Q24197779-A974D218-647F-4D33-A070-93B615F02D1AQ27023734-5F97168D-BDB5-4428-91CB-1CE949FA5F6AQ30496886-A64AD001-5EE6-4695-87AB-BED1427256B7Q33369562-9CCE72E1-FDA4-4056-B561-90B96175E7B6Q33374336-26B2D755-73ED-4FF5-916B-DF2E73A2FB9BQ33392855-A9BE1FC2-77B4-46DA-AC28-44E5197CAD44Q33395509-B93BD724-23B9-4C3D-9C23-BA41891AB0B9Q33403659-8B0CF4A2-E904-4493-A70D-6977EB3CB1C4Q33405052-A3A93F6D-EEBF-4E23-B412-18B3B4D558D1Q33416666-57086AF6-FF37-49E5-B938-92CAD78FCADAQ33436425-1E0E0AB1-1D93-4757-A84F-C0F217E71984Q36798554-E4B1E5D1-BF88-417E-B447-36D314E8A1A3Q38073018-F8833166-E3AF-46DC-A2FF-08B8111DF712Q38235211-A166F1E5-04C9-490C-BF41-0B07D335D980Q38267183-3E3E9292-3DE3-4E30-878D-DAD35453A6AAQ38942854-D7041EF7-C78C-4668-BCEC-2ADA2F99948BQ41264625-E34ADAD2-46B9-487C-89EB-F588FEB87099Q49795614-93559A37-CAE4-46FE-8DD9-B46E38B35D5CQ51742200-9F55CD3D-19C1-4E02-B64D-6A445DA69641Q53160108-B3C23C43-8BC8-4131-94DF-1B1BA6FD5BD3
P2860
The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The efficiency of transfusing ...... inded end point (PROBE) study.
@ast
The efficiency of transfusing ...... inded end point (PROBE) study.
@en
type
label
The efficiency of transfusing ...... inded end point (PROBE) study.
@ast
The efficiency of transfusing ...... inded end point (PROBE) study.
@en
prefLabel
The efficiency of transfusing ...... inded end point (PROBE) study.
@ast
The efficiency of transfusing ...... inded end point (PROBE) study.
@en
P2093
P1433
P1476
The efficiency of transfusing ...... inded end point (PROBE) study.
@en
P2093
Aline Schmidt
Catherine Babault
Catherine Leniger
Delphine Senecal
Elisabeth Hardy
Eric Deconinck
Laurent Bardiaux
Luc Sensebé
Marie-Laure Bidet
P304
P356
10.1182/BLOOD-2004-05-1841
P407
P577
2004-09-14T00:00:00Z